STAT3 and neoplasm: Peripheral and tumor-associated NK cells from STAT3-targeted tumor-bearing mice expressed elevated levels of NK activation markers NKG2D, CD69, Fas ligand (FasL) granzyme B, perforin, and IFNγ, resulting in reduced tumor growth and enhanced survival (80, 81).